10% of Americans are already taking it; GLP-1 is reshaping the pharmaceutical, food, beverage, and restaurant industries.
``` A drug that suppresses appetite is quietly rewriting the American consumption map. According to news from Chasing Wind Trading Desk, on May 19, Deutsche Bank’s head of Global Macro and Thematic Research Jim Reid’s team released a report titled "Quantifying the Impact of GLP-1: Survey Shows Lasting